Cite
HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses - Putative implications for psychiatry and psychopharmacology
MLA
Lappalainen, J., et al. “HTR2C Cys23Ser Polymorphism in Relation to CSF Monoamine Metabolite Concentrations and DSM-III-R Psychiatric Diagnoses - Putative Implications for Psychiatry and Psychopharmacology.” Biological Psychiatry, vol. 46, no. 6, Jan. 1999, pp. 821–26. EBSCOhost, https://doi.org/10.1016/S0006-3223(98)00361-8.
APA
Lappalainen, J., Long, J. C., Virkkunen, M., Ozaki, N., Goldman, D., & Linnoila, M. (1999). HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses - Putative implications for psychiatry and psychopharmacology. Biological Psychiatry, 46(6), 821–826. https://doi.org/10.1016/S0006-3223(98)00361-8
Chicago
Lappalainen, J., J.C. Long, M. Virkkunen, N. Ozaki, D. Goldman, and M. Linnoila. 1999. “HTR2C Cys23Ser Polymorphism in Relation to CSF Monoamine Metabolite Concentrations and DSM-III-R Psychiatric Diagnoses - Putative Implications for Psychiatry and Psychopharmacology.” Biological Psychiatry 46 (6): 821–26. doi:10.1016/S0006-3223(98)00361-8.